Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cytokinetics Inc (CYTK)  
$37.84 1.11 (2.85%) as of 4:30 Tue 8/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 137,271,000
Market Cap: 5.19(B)
Last Volume: 8,264,325 Avg Vol: 8,199,391
52 Week Range: $29.84 - $58.62
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  1083
Guru Rank Value     : 0
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Cytokinetics is a biopharmaceutical company focused on discovering, developing and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. Co.'s clinical-stage drug candidates are: Omecamtiv mecarbil, which is being evaluated for the potential treatment of heart failure; Reldesemtiv, which is being evaluated for treatment in patients with amyotrophic lateral sclerosis; Aficamten, which is an oral, small molecule cardiac myosin inhibitor being evaluated in patients with symptomatic, obstructive hypertrophic cardiomyopathy; and CK-3772271, its second cardiac myosin inhibitor.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 52,295 285,505 410,305 903,416
Total Sell Value $1,796,820 $11,600,773 $18,275,741 $46,976,996
Total People Sold 4 8 9 10
Total Sell Transactions 13 43 68 114
End Date 2025-05-22 2025-02-18 2024-08-20 2023-08-21

   
Records found: 908
  Page 1 of 37  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Malik Fady Ibraham EVP Research & Development   •       •      –    2025-08-19 4 S $38.31 $76,620 D/D (2,000) 140,610     -
   Malik Fady Ibraham EVP Research & Development   •       •      –    2025-08-19 4 OE $10.60 $21,200 D/D 2,000 142,610     -
   Blum Robert I President & CEO   •       •      –    2025-08-15 4 S $38.42 $192,100 D/D (5,000) 383,108     -
   Malik Fady Ibraham EVP Research & Development   •       •      –    2025-08-05 4 S $36.34 $72,680 D/D (2,000) 140,610 -7%     
   Malik Fady Ibraham EVP Research & Development   •       •      –    2025-08-05 4 OE $10.60 $21,200 D/D 2,000 142,610     -
   Blum Robert I President & CEO   •       •      –    2025-07-29 4 S $36.45 $182,250 D/D (5,000) 388,108 -8%     
   Malik Fady Ibraham EVP Research & Development   •       •      –    2025-07-22 4 S $37.47 $74,940 D/D (2,000) 140,610 -3%     
   Malik Fady Ibraham EVP Research & Development   •       •      –    2025-07-22 4 OE $10.60 $21,200 D/D 2,000 142,610     -
   Kaye Edward M. Md Director   •       •      –    2025-07-15 4 A $38.01 $12,467 D/D 328 29,986     -
   Henderson John T Director   •       •      –    2025-07-15 4 A $38.01 $21,248 D/D 559 74,240     -
   Harrington Robert Arthur Director   •       •      –    2025-07-15 4 A $38.01 $12,467 D/D 328 22,643     -
   Wysenski Nancy Director   •       •      –    2025-07-15 4 A $38.01 $6,234 D/D 164 30,774     -
   Wierenga Wendall D Director   •       •      –    2025-07-15 4 A $38.01 $6,234 D/D 164 32,345     -
   Blum Robert I President & CEO   •       •      –    2025-07-14 4 S $38.15 $190,750 D/D (5,000) 393,108 -0%     
   Malik Fady Ibraham EVP Research & Development   •       •      –    2025-07-08 4 S $33.76 $67,520 D/D (2,000) 140,610 -13%     
   Malik Fady Ibraham EVP Research & Development   •       •      –    2025-07-08 4 OE $10.60 $21,200 D/D 2,000 142,610     -
   Blum Robert I President & CEO   •       •      –    2025-07-01 4 S $33.55 $167,750 D/D (5,000) 398,108 -15%     
   Malik Fady Ibraham EVP Research & Development   •       •      –    2025-06-17 4 S $32.91 $65,820 D/D (2,000) 140,610 -19%     
   Malik Fady Ibraham EVP Research & Development   •       •      –    2025-06-17 4 OE $10.60 $21,200 D/D 2,000 142,610     -
   Blum Robert I President & CEO   •       •      –    2025-06-16 4 S $33.80 $169,000 D/D (5,000) 403,108 -14%     
   Callos Andrew EVP, Chief Commercial Officer   •       •      –    2025-06-05 4 S $32.04 $277,434 D/D (8,659) 52,028 -21%     
   Kaye Edward M. Md Director   •       •      –    2025-06-05 4 S $32.10 $116,716 D/D (3,636) 29,658 -21%     
   Malik Fady Ibraham EVP Research & Development   •       •      –    2025-06-03 4 S $31.88 $63,760 D/D (2,000) 140,610 -21%     
   Malik Fady Ibraham EVP Research & Development   •       •      –    2025-06-03 4 OE $10.60 $21,200 D/D 2,000 142,610     -
   Lee Sung EVP, Chief Financial Officer   •       •      –    2025-06-02 4 D $31.21 $154,958 D/D (4,965) 69,477     -
  908 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 37
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us